X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/debiopharm-and-aspen-partner-to-launch-prostate-cancer-drug-trelstar-in-south-africa-301471845.html
https://www.fiercepharma.com/pharma/ipsen-poaches-novartis-vet-mari-scheiffele-to-serve-as-president-its-international-specialty
https://www.prnewswire.com/news-releases/arbor-pharmaceuticals-llc-confirms-availability-of-triptodur-triptorelin-for-patients-with-central-precocious-puberty-301118136.html
https://www.prnewswire.com/news-releases/arbor-pharmaceuticals-llc-confirms-availability-of-triptodur-triptorelin-for-patients-with-central-precocious-puberty-301118136.html#:~:text=ATLANTA%2C%20Aug.%2025%2C%202020,years%20of%20age%20and%20older
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
http://www.prnewswire.com/news-releases/arbor-pharmaceuticals-llc-and-debiopharm-international-sa-announce-commercial-availability-of-triptodur-triptorelin-6-month-formulation-for-treatment-of-central-precocious-puberty-cpp-300529344.html
http://www.prnewswire.com/news-releases/arbor-pharmaceuticals-llc-and-debiopharm-international-sa-announce-us-fda-approval-for-triptodur-triptorelin-6-month-formulation-in-the-treatment-of-central-precocious-puberty-cpp-300482390.html
https://www.europeanpharmaceuticalreview.com/49655/news/industry-news/debiopharms-month-formulation/
http://www.prnewswire.com/news-releases/debiopharm-international-sa-and-eortc-announce-a-collaboration-to-investigate-triptorelin-for-treatment-of-salivary-gland-cancers-565137531.html
http://www.prnewswire.com/news-releases/debiopharm-international-sa-and-arbor-pharmaceuticals-llc-announce-their-us-commercialization-partnership-for-triptorelin-in-central-precocious-puberty-564847701.html
Market Place
Share 
